• Home
  • Search Results

Search Results

374 studies match your search
Open

CAR-T cells targeting the kappa antigen for Relapsed/ Refractory mantle cell and indolent non-Hodgkin lymphomas

Do you have mantle cell lymphoma or other non-Hodgkin lymphoma that has either come back or did not get better with your last treatment? If so, you may be able to take part in a study that will modify your own immune cells to see if it may treat your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Lymphoma)
Open

EVOLVE Study: Understanding risk for depression in the pubertal transition

Help us understand female adolescent depression! Starting at puberty, girls are almost three times more likely to be diagnosed with a mood disorder than boys. The goal of the EVOLVE study is to understand the impact of changing hormones, stress, and sleep on mood symptoms during the pubertal transition.

Age & Gender
  • 11 years ~ 14 years
  • Female, Gender Inclusive
Study Interest
  • Behavior
  • Child and Teen Health
  • Glands and Hormones
  • and 10 more
Open

Kinship Care Study

For caregivers of grieving children who weren't the romantic partner of the parent who died (if you weren't together as a couple) at the time of their death, please help us better understand your experience. Sharing your thoughts will help us create better resources and support for families like yours.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Mental and Emotional Health
  • Wellness and Lifestyle
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Open

Study of Acalabrutinib in Relapsed/Refractory CNS Lymphomas

Have you been diagnosed with central nervous system (CNS) lymphoma? Have you received treatment for this disease, but it either came back or did not improve? Then you may be eligible to participate ind a study to look at the safety and effectiveness of the new study drug acalabrutinib.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants with Normal and Impaired Kidney Function

Have you been diagnosed with multiple myeloma? If so, you may be able to take part in a research study looking at the safety of giving a new drug called Belantamab Mafodotin to patients with multiple myeloma and normal or impaired kidney function.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

Registry of kidney patients with monoclonal gammopathies

If you are seen at UNC and have been diagnosed with monoclonal gammopathies or amyloidosis, and the disease is affecting your kidneys, we would like your permission to access your medical record to learn about your treatments and how well they work.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Rare Diseases
Visit Location
100% Remote (online, phone, text)
Open

Speech patterns in healthy adults

Are you interested in speech and language? If you have had a stroke you may be able to take part in a study to help us understand speech patterns.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Brain, Head, Nervous System
  • Healthy Volunteer or General Population
  • Language and Speech
Open

Biomechanical Changes Following ACL Injury that Influence PTOA

Have you recently had an anterior cruciate ligament re-injury and will be undergoing revision anterior cruciate ligament reconstruction surgery? If so, you may be able to participate in a study assessing the associations between walking movement and physical activity with knee joint health. Compensation provided.

Age & Gender
  • 16 years ~ 50 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Wellness and Lifestyle
  • Women's Health
  • and 3 more
Open

ACL Surgery Rehabilitation Study

Are you scheduled for or have you recently undergone ACL reconstruction surgery? You may be able to participate in a study research study to help us learn if a new form of rehabilitation improves outcomes. All rehabilitation/physical therapy costs are covered by the study. Compensation is also provided. All of the groups will receive standard care treatment, but two of the groups will also receive different types of vibration.

Age & Gender
  • 16 years ~ 35 years
  • Male, Female
Study Interest
  • Bones, Joints, Muscles
Open

CureGN (Cure Glomerulonephropathy)

The CureGN Network acts as a "library" of data for investigators across the world to use to help us ask the following questions: 1) What is the disease?; 2) Why did it happen to me?; 3) Can it be passed down to my family members?; 4) What treatments work the best with the least side effects?

Age & Gender
  • 0 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
  • Rare Diseases
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research